BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36507881)

  • 21. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
    Bae SU; Won KS; Song BI; Jeong WK; Baek SK; Kim HW
    Cancer Imaging; 2018 Sep; 18(1):32. PubMed ID: 30217167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
    Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
    Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The improved accuracy of planar bone scintigraphy by adding single photon emission computed tomography (SPECT-CT) to detect skeletal metastases from prostate cancer.
    McLoughlin LC; O'Kelly F; O'Brien C; Sheikh M; Feeney J; Torreggiani W; Thornhill JA
    Ir J Med Sci; 2016 Feb; 185(1):101-5. PubMed ID: 25394725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of quantitative bone SPECT/CT for evaluating medication-related osteonecrosis of the jaw treatment response.
    Moridera K; Kitajima K; Yoshikawa K; Takaoka K; Tsuchitani T; Noguchi K; Kishimoto H; Yamakado K
    Jpn J Radiol; 2023 Jul; 41(7):760-767. PubMed ID: 36656541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of bone SUV obtained from different SPECT/CT systems.
    Yoshimura M; Kugai N; Aida T; Hakamata D; Miyajima N; Takahashi Y
    Hell J Nucl Med; 2023; 26(3):181-186. PubMed ID: 38085833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single photon emission computed tomography/spiral computed tomography fusion imaging for the diagnosis of bone metastasis in patients with known cancer.
    Zhao Z; Li L; Li F; Zhao L
    Skeletal Radiol; 2010 Feb; 39(2):147-53. PubMed ID: 19669135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of quantitative bone SPECT/CT for medication-related osteonecrosis of the jaw in clinical settings.
    Moridera K; Kitajima K; Yoshikawa K; Takaoka K; Tsuchitani T; Noguchi K; Kishimoto H; Yamakado K
    Jpn J Radiol; 2022 May; 40(5):492-499. PubMed ID: 34851501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-photon Emission CT Combined with Spiral CT for Early Detection and Localization of Bone Metastasis: A Review.
    Okudan B; Arıcan P; Seven B
    Curr Med Imaging; 2020; 16(5):507-512. PubMed ID: 32484085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of 99mTc-MDP SPECT/spiral CT combined with three-phase bone scintigraphy in assessing suspected bone tumors in patients with no malignant history.
    Zhang Y; Shi H; Li B; Xiu Y; Cai L; Gu Y; Chen S
    Nucl Med Commun; 2015 Jul; 36(7):686-94. PubMed ID: 25757199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.
    Shin DS; Shon OJ; Byun SJ; Choi JH; Chun KA; Cho IH
    Skeletal Radiol; 2008 May; 37(5):415-21. PubMed ID: 18309481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions.
    Savelli G; Maffioli L; Maccauro M; De Deckere E; Bombardieri E
    Q J Nucl Med; 2001 Mar; 45(1):27-37. PubMed ID: 11456373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.
    Xu R; Kido S; Suga K; Hirano Y; Tachibana R; Muramatsu K; Chagawa K; Tanaka S
    Ann Nucl Med; 2014 Nov; 28(9):926-35. PubMed ID: 25107363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Prognostic Value of Quantitative Bone SPECT/CT Before
    Dittmann H; Kaltenbach S; Weissinger M; Fiz F; Martus P; Pritzkow M; Kupferschlaeger J; la Fougère C
    J Nucl Med; 2021 Jan; 62(1):48-54. PubMed ID: 32444369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT.
    Rohren EM; Etchebehere EC; Araujo JC; Hobbs BP; Swanston NM; Everding M; Moody T; Macapinlac HA
    J Nucl Med; 2015 Oct; 56(10):1507-12. PubMed ID: 26135112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should SPECT-CT replace SPECT for the evaluation of equivocal bone scan lesions in patients with underlying malignancies?
    Ndlovu X; George R; Ellmann A; Warwick J
    Nucl Med Commun; 2010 Jul; 31(7):659-65. PubMed ID: 20395878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT.
    Utsunomiya D; Shiraishi S; Imuta M; Tomiguchi S; Kawanaka K; Morishita S; Awai K; Yamashita Y
    Radiology; 2006 Jan; 238(1):264-71. PubMed ID: 16304081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET/CT features discriminate risk of metastasis among single-bone FDG lesions detected in newly diagnosed non-small-cell lung cancer patients.
    Lim CH; Ahn TR; Moon SH; Cho YS; Choi JY; Kim BT; Lee KH
    Eur Radiol; 2019 Apr; 29(4):1903-1911. PubMed ID: 30315418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maximum Standardized Uptake Value of (99m)Tc Hydroxymethylene Diphosphonate SPECT/CT for the Evaluation of Temporomandibular Joint Disorder.
    Suh MS; Lee WW; Kim YK; Yun PY; Kim SE
    Radiology; 2016 Sep; 280(3):890-6. PubMed ID: 27035060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.